The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.Continue reading
Category Archives: Blogs
AZBio Blogs
AdvaMed’s Steve Ubl Announces Move to PhRMA
Steve Ubl, president and CEO of AdvaMed will leave his post at AdvaMed in the fall to serve as president and CEO of PhRMA.
Ubl shared the letter below with the AdvaMed Board of Directors on Friday, September 25, 2015.Continue reading
Washington Update – Fall Preview
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.
Continue reading
H.R. 1599: Safe and Accurate Food Labeling Act of 2015 Passed in the House
The Safe and Accurate Food Labeling Act will ensure that food labeling in the United States is consistent across state lines and based on sound science. Continue reading
Now Is the Time to Fix H.R. 9: The American Innovation Act
As currently written, H.R. 9 – The American Innovation Act poses significant challenges for life science innovation. Continue reading
Comments open on MDUFA IV
It seems like only yesterday that Congress, the FDA, and industry came together to reauthorize the Medical Device User Fee Agreement (MDUFA III). Now the process begins again as we prepare for MDUFA IV.Continue reading
Safe and Accurate Food Labeling Act (H.R.1599) Advances
Bipartisan action on July 14, 2015 by the U.S. House Agriculture Committee advances the Safe and Accurate Food Labeling Act (H.R. 1599).Continue reading
A Vote for Our Future: 21st Century Cures Passes in the House
In a 344 to 77 vote, the U.S. House of Representatives passed H.R.6: The 21st Century Cures Act on the morning of July 10, 2015. Continue reading
21st Century Cures Progresses
21st Century Cures passes unanimously out of the House Energy and Commerce Committee.
“AZBio congratulates Members of the House Energy and Commerce Committee and all of the representatives of industry, patients, and our key federal agency partners on a truly collaborative effort to progress H.R. 6 – The 21st Century Cures Act.” Joan Koerber-Walker, President & CEO, Arizona Bioindustry Association (AZBio) and Chair, AdvaMed State Medical Technology Alliance Continue reading
5 Keys To Revitalizing The Medtech Innovation Ecosystem
America’s medical technology industry creates life-saving and life-enhancing treatments and cures that drive efficiencies and cost savings in the health care system, improve the quality of patient care, and generate high-quality jobs that contribute to economic growth. But today, the innovation ecosystem that supports medical technology development is severely stressed. The U.S. has historically been the world leader in medical technology, but our leadership is eroding. To respond to these challenges, AdvaMed has proposed a new Innovation Agenda.